Charta Health vs CodaMetrix (2026)
Two model driven coding platforms with different jobs and different reach. Charta runs a pre bill review across every outpatient encounter, reading each note as it closes to catch missed revenue and compliance gaps, then autocorrecting in the EHR or queuing the chart, with configurable oversight and a citation back to the source behind every suggestion. CodaMetrix codes and bills autonomously at health system scale, across radiology, pathology, surgery, endoscopy, specialty services and inpatient care, and measures quality against Rosetta, a coding framework reviewed by a council of health system leaders. Both share the category's core tension, since a tool measured in captured revenue leans toward upcoding, and neither publishes evidence by group that its model is calibrated rather than optimized for revenue. If your failure mode is outpatient charts going out with missed revenue and compliance gaps, start with Charta. If your failure mode is automating primary coding across many specialties including inpatient, start with CodaMetrix, and ask for its routing threshold.
- Comprehensive pre bill review is the design: rather than coding a sample, Charta reads every encounter as the note closes, flags missed revenue and compliance gaps while the chart is still open, and either autocorrects in the EHR or queues the problem chart.
- Configurable oversight with a real validation affordance: the practice sets whether Charta codes autonomously, autocorrects or queues for review, and every suggestion carries a citation back to the source documentation so a reviewer checks it rather than accepts it blind.
- SOC 2 and GDPR are stated, with reports available on request.
- Specialty reach across radiology, pathology, surgery and endoscopy, specialty services and inpatient care, for facility and professional fee coding, where Charta targets outpatient and ambulatory encounters.
- Deployment at academic medical centers including Mass General Brigham, where it was spun out, Yale Medicine, University of Colorado Medicine and Henry Ford Health, and named 2026 Best in KLAS for Autonomous Medical Coding.
- Autonomous primary coding routed to billing rather than a review layer, for health systems that want the coding function itself automated at scale.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Charta Health and CodaMetrix are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Charta Health | CodaMetrix |
|---|---|---|
| Primary category | Autonomous Medical Coding | Autonomous Medical Coding |
| Founded | 2023 | 2019 |
| Headquarters | San Francisco, California, United States | Boston, Massachusetts, United States |
| Website | chartahealth.com | codametrix.com |
Side by Side
Select any grade to read the note behind it.
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
Charta Health reviews the documentation for every encounter before billing, using large language models rather than a rules engine. For providers it codes each visit after the note closes, corrects coding directly in the EHR or queues problem charts for a person, and cites the supporting documentation on each suggestion; revenue discovery, payer compliance, clinical quality analytics, clinical documentation improvement and provider feedback run on the same review.
Source: AI Health Index, July 2026
CodaMetrix sells autonomous medical coding. Spun out of Mass General Brigham in 2019 from coding AI its founding team built inside that health system in 2016, it offers CMX CARE, a platform that ingests clinical notes (including ambient documentation), registration events, surgical schedules, orders and charges, builds a longitudinal view of each patient's care, and codes and bills facility and professional fee encounters across radiology, pathology, surgery and endoscopy, specialty services and inpatient care.
Source: AI Health Index, July 2026
Questions buyers ask
How are Charta Health and CodaMetrix priced and sold?
Charta sells to provider organizations, health systems, MSOs and payers, builds each integration with dedicated engineering support, and measures its value as revenue uplift in RVUs per encounter. Whether the fee is per encounter, per provider or a share of uplift is not stated, and a fee that scales with uplift would reward higher coding.
With CodaMetrix, the commercially important unknown is whether pricing is per chart, per provider, or subscription, which determines whether savings scale with automation rate or are captured by the vendor. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.
How do Charta Health and CodaMetrix handle patient data?
Charta reads all provider documentation for every encounter, faxes and scanned images included, and tunes each implementation on the client's review feedback; its FAQ states HIPAA, SOC 2 and GDPR compliance. Retention, de identification, whether client documentation trains models used for other clients, and which model provider receives the notes are not stated.
For CodaMetrix, the solution page says the platform continuously learns, in real time, from coding decisions made by the customer's team and by the coding teams of top performing health systems, and the company's security material says it analyzes denials information shared by customers to improve its models. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.
Which settings and specialties do Charta Health and CodaMetrix cover?
Inpatient facility coding is not the target, although Charta says any organization with a reason to audit charts can use it.
In CodaMetrix's case, the market is United States health systems, from academic centers to smaller organizations. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.
What evidence is published for Charta Health and CodaMetrix?
For Charta Health, an FQHC case study found missed revenue on 25 percent of notes. Pre bill coverage measures scope rather than accuracy, and none of the figures carries a baseline or outside audit.
With CodaMetrix, several named academic customers are also investors through their physician organizations, which signals alignment and is also a caveat on independence. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
Both carry the tension a buyer must probe hardest: a coding engine whose value is measured in captured revenue has an incentive gradient toward upcoding. Charta measures its result as roughly 11 percent more RVUs per patient and is tuned to find missed revenue. CodaMetrix learns continuously from coding decisions across its customers and from denials, which can carry a system's historical coding intensity forward; it reports 98 percent average coding accuracy and measures quality against its Rosetta framework, but publishes no performance by specialty or group.
The posture differs. Charta is a pre bill review with configurable oversight and source citations. CodaMetrix codes touchlessly and sends the cases it does not code to coders, without publishing the confidence threshold that decides which is which. CodaMetrix reaches inpatient and facility coding that Charta does not target.
Several of CodaMetrix's named academic customers are also investors, an alignment signal and an independence caveat. Neither publishes pricing.